Eli Lilly CEO says Medicare price negotiations could harm drug development
The CEO said the "biggest problem" with the Inflation Reduction Act provision stems from a difference in timeline for negotiating
Read More
Novartis AG
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
CAR-T immunotherapies and antibody drug conjugates will highlight the American Society of Clinical Oncology's cancer research conference that starts Thursday.
Read More
Radioligand therapy, a ‘game-changer’ for cancer treatment, forces manufacturers to race against a ticking clock
Radioligand therapy is a 'game -hanger' for cancer treatment, but it forces manufacturers to race against a ticking clock. Source
Read More
Novartis says operating profit to grow again ahead of Sandoz spin off
The Swiss drugmaker reported full-year core operating income was broadly flat at $16.7 billion. Source link
Read More
CNBC Pro Talks: "Fast Money" trader Tim Seymour reveals what he's buying in the new year
Investors are looking for a fresh start for the markets after 2022 hit several sectors hard. Since September, "Fast Money"
Read More
Bank of America says these stocks have the most ‘potential upside’ this holiday season
Here are the biggest calls on Wall Street on Source link
Read More
Goldman says these ‘attractive stocks’ still have more room to run
Here are the biggest calls on Wall Street on Source link
Read More
Goldman Sachs analysts reveal the most attractive stocks on Wall Street following earnings
Here are the biggest calls on Wall Street on Source link
Read More
Goldman Sachs says these global companies are poised to return more cash to shareholders
Investors seeking returns in a beaten-down market could turn to companies buying back their shares. Goldman names the stocks it
Read More